These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 33442994)
1. Biomarkers of human gut microbiota diversity and dysbiosis. Rüb AM; Tsakmaklis A; Gräfe SK; Simon MC; Vehreschild MJ; Wuethrich I Biomark Med; 2021 Feb; 15(2):137-148. PubMed ID: 33442994 [TBL] [Abstract][Full Text] [Related]
2. Exploration of the Fecal Microbiota and Biomarker Discovery in Equine Grass Sickness. Leng J; Proudman C; Darby A; Blow F; Townsend N; Miller A; Swann J J Proteome Res; 2018 Mar; 17(3):1120-1128. PubMed ID: 29364680 [TBL] [Abstract][Full Text] [Related]
3. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS. Sitkin SI; Tkachenko EI; Vakhitov TY Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418 [TBL] [Abstract][Full Text] [Related]
4. The role of intestinal microbiota in cardiovascular disease. Jin M; Qian Z; Yin J; Xu W; Zhou X J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327 [TBL] [Abstract][Full Text] [Related]
5. The central and biodynamic role of gut microbiota in critically ill patients. Wozniak H; Beckmann TS; Fröhlich L; Soccorsi T; Le Terrier C; de Watteville A; Schrenzel J; Heidegger CP Crit Care; 2022 Aug; 26(1):250. PubMed ID: 35982499 [TBL] [Abstract][Full Text] [Related]
6. The gut microbiota and its interactions with cardiovascular disease. Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651 [TBL] [Abstract][Full Text] [Related]
7. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Sun MF; Shen YQ Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121 [TBL] [Abstract][Full Text] [Related]
8. Multi-Compartment Profiling of Bacterial and Host Metabolites Identifies Intestinal Dysbiosis and Its Functional Consequences in the Critically Ill Child. Wijeyesekera A; Wagner J; De Goffau M; Thurston S; Rodrigues Sabino A; Zaher S; White D; Ridout J; Peters MJ; Ramnarayan P; Branco RG; Torok ME; Valla F; Meyer R; Klein N; Frost G; Parkhill J; Holmes E; Pathan N Crit Care Med; 2019 Sep; 47(9):e727-e734. PubMed ID: 31169619 [TBL] [Abstract][Full Text] [Related]
9. Exploring the significance of microbiota metabolites in rheumatoid arthritis: uncovering their contribution from disease development to biomarker potential. Lu ZF; Hsu CY; Younis NK; Mustafa MA; Matveeva EA; Al-Juboory YHO; Adil M; Athab ZH; Abdulraheem MN APMIS; 2024 Jun; 132(6):382-415. PubMed ID: 38469726 [TBL] [Abstract][Full Text] [Related]
10. Gut-microbiota derived bioactive metabolites and their functions in host physiology. Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130 [TBL] [Abstract][Full Text] [Related]
11. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735 [TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota in Cardiovascular Health and Disease. Tang WH; Kitai T; Hazen SL Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349 [TBL] [Abstract][Full Text] [Related]
13. Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease. Li Q; Larouche-Lebel É; Loughran KA; Huh TP; Suchodolski JS; Oyama MA mSystems; 2021 Apr; 6(2):. PubMed ID: 33879495 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122 [TBL] [Abstract][Full Text] [Related]
15. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota. Salminen A J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399 [TBL] [Abstract][Full Text] [Related]
16. Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children. Zhang C; Yin A; Li H; Wang R; Wu G; Shen J; Zhang M; Wang L; Hou Y; Ouyang H; Zhang Y; Zheng Y; Wang J; Lv X; Wang Y; Zhang F; Zeng B; Li W; Yan F; Zhao Y; Pang X; Zhang X; Fu H; Chen F; Zhao N; Hamaker BR; Bridgewater LC; Weinkove D; Clement K; Dore J; Holmes E; Xiao H; Zhao G; Yang S; Bork P; Nicholson JK; Wei H; Tang H; Zhang X; Zhao L EBioMedicine; 2015 Aug; 2(8):968-84. PubMed ID: 26425705 [TBL] [Abstract][Full Text] [Related]
17. Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer. Marzhoseyni Z; Shaghaghi Z; Alvandi M; Shirvani M Curr Cancer Drug Targets; 2024; 24(6):612-628. PubMed ID: 38213140 [TBL] [Abstract][Full Text] [Related]
18. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. Rizzetto L; Fava F; Tuohy KM; Selmi C J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127 [TBL] [Abstract][Full Text] [Related]
19. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer? Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126 [TBL] [Abstract][Full Text] [Related]
20. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases. Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]